SCHEMBL19794340

SCHEMBL19794340

Clc1ccccc1-c1cc(-c2ccccc2Cl)nc(-c2ccccc2Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.56
HSP90AB1 P08238 1/20 0.56
CYP2A6 P11509 1/20 0.54
IDO1 P14902 1/20 0.47
ADORA2A P29274 2/20 0.46
ADORA1 P30542 2/20 0.46
BACE1 P56817 1/20 0.46
TRPA1 O75762 1/20 0.46
MAOB P27338 1/20 0.44
KDM5B Q9UGL1 1/20 0.44
PDK2 Q15119 1/20 0.44
LTB4R Q15722 1/20 0.43
ALPL P05186 2/20 0.42
CYP19A1 P11511 1/20 0.42
HPGD P15428 3/20 0.42
NPC1 O15118 2/20 0.42
TP53 P04637 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28318285 0.88 CYP2A6 (0.61) HSP90AA1HSP90AB1CYP2A6ADORA2AADORA1
SCHEMBL30749488 0.81 CCR1 (0.62) HSP90AA1CYP2A6ALPLCYP19A1HPGD
SCHEMBL9762462 0.81 CYP2A6 (0.70) HSP90AA1HSP90AB1CYP2A6BACE1TRPA1
SCHEMBL16150268 0.80 CYP2A6 (0.56) HSP90AA1HSP90AB1CYP2A6BACE1TRPA1
SCHEMBL29287261 0.79 PTGS2 (0.46) HSP90AA1HSP90AB1CYP2A6IDO1ADORA2A
SCHEMBL14529286 0.77 ADORA2A (0.56) HSP90AA1HSP90AB1CYP2A6ADORA2AADORA1
SCHEMBL17413558 0.77 MAOB (0.44) HSP90AA1HSP90AB1CYP2A6IDO1ADORA2A
SCHEMBL7702897 0.77 BACE1 (0.57) HSP90AA1HSP90AB1CYP2A6ADORA2AADORA1
SCHEMBL19537421 0.77 CYP2A6 (0.52) HSP90AA1HSP90AB1CYP2A6BACE1TRPA1
SCHEMBL22582681 0.76 KMT2A (0.57) HSP90AA1HSP90AB1CYP2A6ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC HSP90AA1 4412/4885HSP90AB1 4590/4885CYP2A6 3821/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 HSP90AA1 4143/4885HSP90AB1 4509/4885CYP2A6 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.